- New awards
- 953
- in the last 12 months
- Median award
- $46K
- first-year award (total costs)
- Middle half
- $42K to $50K
- 25th to 75th percentile
- Top institute
- NIAID
- 256 awards
About the NIH F31
The F31 supports a doctoral student's dissertation research and training under a sponsor. Reviewers look at the applicant, the sponsor and environment, the research plan and the training plan as a whole.
Several F31 versions exist, including one to enhance the diversity of the research workforce, and not every institute takes every version.
- Project length
- Up to 5 years in total, depending on the institute
- Who applies
- Doctoral students enrolled in a research doctoral program
- Research Strategy
- Usually 6 pages, plus a 1-page Specific Aims
- Budget
- Stipend and allowances at the current NRSA rates
Limits change between notices: the notice you apply to is what counts.
Open NIH F31 opportunities
All NIH fundingRecently funded NIH F31 projects
- Identification of causal DNA variants that influence gene expression in trans
Kevin H Zhan · University of Minnesota, MN · NHGRI · $50K · Sep 23, 2026
Genetic variation underlies much of the phenotypic variation in important traits, including morphological and physiological phenotypes as well as risk for common diseases, among individuals. Population-scale genome- wide association studies (GWAS) have identified thousands of genetic loci containing variants…
- Regulation of Cardiac Fibrosis by Substance P Receptors
Kallie Schafner · West Virginia University, WV · NHLBI · $50K · Sep 17, 2026
This proposal aims to explore cellular and molecular mechanisms of cardiac fibrosis and diastolic dysfunction, key contributors to heart failure with preserved ejection fraction (HFpEF), a condition with a poor prognosis and no effective treatments. The focus of this proposal is on the Mas-related G protein-coupled…
- Examining Real-World Uptake and Effectiveness of GLP-1 RA in an Urban Population with Type-2 Diabetes
Christian Victoria · New York University School of Medicine, NY · NIDDK · $37K · Sep 17, 2026
Type 2 diabetes (T2D) affects nearly 30% of Americans aged 65 and older, with significant variation in treatment quality across healthcare settings. Recent American Diabetes Association (ADA) guidelines recommend GLP-1 receptor agonists (GLP-1 RAs) as preferred second-line agents due to their cardiovascular and weight…
- Establishing the Mechanisms of Antiretroviral Induced Osteoporosis and Obesity
Itzel Lazcano · Rush University Medical Center, IL · NIAMS · $50K · Sep 17, 2026
Antiretroviral therapy (ART) effectively suppresses HIV infection but continues to contribute to long-term comorbidity risks, including osteoporosis and obesity. In this fellowship training proposal, I will examine how two commonly prescribed antiretrovirals, tenofovir disoproxil fumarate (TDF) and tenofovir…
- Development of Chemical Tools to Probe the Role of CHD1 in Viral Proliferation
Adam Funk · Univ of North Carolina Chapel Hill, NC · NIAID · $41K · Sep 17, 2026
Influenza is contracted by upwards of a billion people within a single season. Influenza proliferation is promoted by Chromodomain Helicase DNA Binding Protein 1 (CHD1), a human chromatin remodeling factor, and this phenotype extends across multiple subtypes of influenza A. While the exact mechanism of how CHD1…
- Investigating the Role of Gustatory Cortical Dynamics in Foraging Behaviors
Rafael Gabriel · Brandeis University, MA · NIDCD · $36K · Sep 17, 2026
This project addresses a fundamental question in neuroscience: how does the brain integrate sensory experience into memory systems to support adaptive behavior? Although the hippocampus is widely recognized as a cognitive map, it remains unclear what features of experience are incorporated into this representation and…
- Molecular mechanisms and neural impact of human microglia immune tolerance
Victoria Cuevas · Baylor College of Medicine, TX · NEI · $50K · Sep 17, 2026
Proper brain development requires the precise pruning of excess synapses by resident innate immune cells called microglia. Proper microglial responses to immune stimuli are therefore essential for normal brain function, and disruptions in microglial activity and synaptic connectivity contribute to autism, epilepsy,…
- Using a Cataract Model to Investigate Redox Imbalance, Cellular Senescence, and Inflammation in Aging and Age-Related Cataracts
Ying Qin · University of North Texas Hlth Sci Ctr, TX · NEI · $44K · Sep 16, 2026
Age-related cataract (ARC) is the most common age-associated eye disease and the leading cause of reversible blindness worldwide. Although cataract surgery is effective, it neither targets disease mechanisms nor prevents progression, and access, especially for older and underserved populations, remains limited.…
- Naturalistic Film-Based Memory: Links to Tau Burden, LC Integrity, and Network Dynamics
Daisy Martha Kiyemba · Brandeis University, MA · NIA · $36K · Sep 16, 2026
Episodic memory is among the earliest cognitive functions affected by aging and Alzheimer’s disease (AD), with subtle deficits often emerging before clinical diagnosis. Two key biomarkers of early AD pathology including tau accumulation and locus coeruleus (LC) degeneration have been independently associated with…
- Unraveling microglia-intrinsic sex-specific properties and their contribution to Alzheimer's disease pathology
Lia Calcines Rodriguez · University of Rochester, NY · NIA · $50K · Sep 14, 2026
In Alzheimer’s disease (AD), the most common form of dementia, women are more susceptible with greater rates of cognitive decline, brain atrophy, and increased global pathology compared to men. AD is characterized by amyloid-β (Aβ) plaques, neurofibrillary tangles and neuroinflammation. In multiple rodent models of…
- The role of astrocytes in TRN dysfunction and sleep disruption in Alzheimer's disease
Joseph Robert Campbell · Baylor College of Medicine, TX · NIA · $50K · Sep 14, 2026
The occurrence of age-related illnesses such as Alzheimer's disease (AD) is globally on the rise. Yet, effective strategies to treat or alleviate its devastating consequences are still lacking. This is due to the fact that significant pathological changes in the brain have already occurred by the time individuals are…
- Longitudinal examination of subsystem-specific decline in speech motor control and functional communication in Parkinson's disease
Daphne Toglia · Boston University Medical Campus, MA · NIDCD · $50K · Sep 14, 2026
Parkinson’s disease (PD) is a debilitating and progressive brain disorder affecting 1 million Americans and is the fastest growing neurodegenerative disorder in the world. Because PD currently has no cure, its toll on patients, families, and the healthcare system continues to mount. Although widely recognized for…
- Investigating the role of CD63 in microglia tau clearance
Jonathan Hacker · Tufts University Boston, MA · NIA · $46K · Sep 14, 2026
Establishing effective disease-modifying treatments for Alzheimer’s Disease (AD) remains a major medical challenge. Neuron death and cognitive decline in AD correlate strongly with the pathological spread and accumulation of hyperphosphorylated tau aggregates. Emerging evidence implicates microglia, the primary…
- Neural and Computational Mechanisms of Subjective Perceptual Precision
Jeffrey Allen Nestor · Boston University (Charles River Campus), MA · NEI · $40K · Sep 14, 2026
Human observers are constantly faced with unreliability in their internal sensory signals, either due to internal or external noise. Remarkably, we are able to metacognitively access this sensory uncertainty through our intuitive sense of subjective uncertainty, which facilitates decision-making in situations…
- Isoform-Specific Functions of Espin Variants in Auditory and Vestibular Hair Cells
Andrew Faris Paquette · University of Virginia, VA · NIDCD · $40K · Sep 11, 2026
Hearing loss is the third most common chronic condition in the United States, affecting approximately 30 million adults and contributing to social isolation, depression, and cognitive decline. Hearing and balance depend on the proper formation and maintenance of stereocilia, the mechanosensory projections of inner ear…
Institutions with the most new NIH F31 awards
- 1University of Michigan at Ann Arbor, MI36
- 2University of Pennsylvania, PA36
- 3Yale University, CT33
- 4Emory University, GA32
- 5Univ of North Carolina Chapel Hill, NC29
- 6Vanderbilt University, TN29
- 7University of Colorado Denver, CO26
- 8Duke University, NC21
- 9University of California, San Diego, CA21
- 10Harvard Medical School, MA19
How to write it
All guidesGrantee reads the notice, sets up every required section with its page limit and drafts each one with you, then checks the draft against the requirements before you submit.
Start freeGet new funding every Monday
New federal opportunities and upcoming deadlines for NIH F31 and more, in one short email. Free, unsubscribe anytime.
New NIH F31 awards with notice dates from Oct 27, 2025 to Oct 27, 2026, from NIH RePORTER. Amounts are the first-year award, direct plus indirect costs. Updated Oct 27, 2026.